Capital7 invests in Allied BioScience

Allied BioScience, a maker of residual antiviral surface coating, has secured an undisclosed amount of Series C funding.

Allied BioScience, a maker of residual antiviral surface coating, has secured an undisclosed amount of Series C funding. The investors included Capital7.

Source: Press Release